These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36656363)

  • 21. Pharmacokinetic evaluation of [
    Kramer V; Juri C; Riss PJ; Pruzzo R; Soza-Ried C; Flores J; Hurtado A; Rösch F; Chana-Cuevas P; Amaral H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1927-1937. PubMed ID: 31788709
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
    J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.
    Fan Z; Calsolaro V; Atkinson RA; Femminella GD; Waldman A; Buckley C; Trigg W; Brooks DJ; Hinz R; Edison P
    J Nucl Med; 2016 Nov; 57(11):1753-1759. PubMed ID: 27261523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.
    Milak MS; DeLorenzo C; Zanderigo F; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2010 Dec; 51(12):1892-900. PubMed ID: 21098796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.
    Parsey RV; Slifstein M; Hwang DR; Abi-Dargham A; Simpson N; Mawlawi O; Guo NN; Van Heertum R; Mann JJ; Laruelle M
    J Cereb Blood Flow Metab; 2000 Jul; 20(7):1111-33. PubMed ID: 10908045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D
    Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S
    Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo quantification of 5-HT1A-[18F]MPPF interactions in rats using the YAP-(S)PET scanner and a beta-microprobe.
    Millet P; Moulin M; Bartoli A; Del Guerra A; Ginovart N; Lemoucheux L; Buono S; Fagret D; Charnay Y; Ibáñez V
    Neuroimage; 2008 Jul; 41(3):823-34. PubMed ID: 18436452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain.
    Passchier J; van Waarde A; Vaalburg W; Willemsen AT
    J Nucl Med; 2001 Jul; 42(7):1025-31. PubMed ID: 11438622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region.
    Hirvonen J; Kajander J; Allonen T; Oikonen V; Någren K; Hietala J
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):185-95. PubMed ID: 16685258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo.
    Marner L; Gillings N; Comley RA; Baaré WF; Rabiner EA; Wilson AA; Houle S; Hasselbalch SG; Svarer C; Gunn RN; Laruelle M; Knudsen GM
    J Nucl Med; 2009 Jun; 50(6):900-8. PubMed ID: 19470850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
    Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic modeling of [
    Jin H; Yue X; Liu H; Han J; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z
    J Neurochem; 2018 Mar; 144(6):791-804. PubMed ID: 29315563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.
    Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
    Psychopharmacology (Berl); 2012 May; 221(2):261-72. PubMed ID: 22147258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.